Monday, 28 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14486
Articles
Company
Deals
Fosun Pharma Secures Licensing Deal for HCB101 SIRPα-Fc Fusion Protein
July 1, 2025
Company
Drug
Zai Lab’s Bemarituzumab Meets Phase III Endpoint in Gastric Cancer Trial
July 1, 2025
Company
Drug
Hengrui Pharmaceuticals’ Aihengping Gains NMPA Approval for Regional Analgesia
July 1, 2025
Company
Drug
Avistone’s Vebreltinib Wins NMPA Approval for MET-Amplified NSCLC
July 1, 2025
Company
Drug
Hengrui Pharmaceuticals Gains NMPA Approval for Aisuda in Severe Alopecia Areata
July 1, 2025
Company
Medical Device
MicroPort NeuroTech’s NUMEN Nest Gains FDA Marketing Approval
July 1, 2025
Company
Drug
BMS Secures FDA Approval for Updated Labels of Breyanzi and Abecma
July 1, 2025
Company
Deals
GenScript Receives $213.8M Payment from LaNova for PD-1 Antibody License
June 30, 2025
Company
Drug
UCB’s Fenfluramine Shows Positive Results in Phase III GEMZ Study for CDKL5 Deficiency Disorder
June 30, 2025
Company
Deals
Sunshine Lake Pharma Lists on HKEX via Introduction Method
June 30, 2025
Company
Deals
MGI Tech Partners with Italy’s Negedia to Advance Genomic Sequencing and Spatial Transcriptomics
June 30, 2025
Policy / Regulatory
China Proposes Healthcare Security Law to Strengthen Medical Insurance System
June 30, 2025
1
2
…
322
323
324
325
326
…
1,207
1,208
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?